Pulmonary Fibrosis Patients, Advocacy Groups Applaud FDA Decision to Add Untreatable Lung Disease as Part of Five-Year Patient-Focused Drug Development Program CULVER CITY, Calif., April 16, 2013 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) and the Pulmonary Fibrosis Foundation (PFF) today applaud the FDA for including Idiopathic Pulmonary...